Cargando…

Rifaximin Modulates the Gut Microbiota to Prevent Hepatic Encephalopathy in Liver Cirrhosis Without Impacting the Resistome

The gut microbiota has an important role in the pathogenesis of hepatic encephalopathy(HE). Rifaximin, an intestinal non-absorbable antibacterial agent, is effective in the treatment of HE. However, whether long-term prophylactic use induces antibacterial resistance and its mechanism for treating HE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Xiao, Jin, Ye, Zhou, Wangxiao, Xiao, Tingting, Wu, Zhongwen, Su, Junwei, Gao, Hainv, Shen, Ping, Zheng, Beiwen, Luo, Qixia, Li, Lanjuan, Xiao, Yonghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804384/ https://www.ncbi.nlm.nih.gov/pubmed/35118004 http://dx.doi.org/10.3389/fcimb.2021.761192

Ejemplares similares

Rifaximin Alters Intestinal Microbiota and Prevents Progression of Ankylosing Spondylitis in Mice
por: Yang, Lianjun, et al.
Publicado: (2019)

Disordered Intestinal Microbial Communities During Clostridioides difficile Colonization and Subsequent Infection of Hepatic Cirrhosis Patients in a Tertiary Care Hospital in China
por: Chen, Yunbo, et al.
Publicado: (2022)

Alterations in the gut microbiota and the efficacy of adjuvant probiotic therapy in liver cirrhosis
por: Wu, Zengrong, et al.
Publicado: (2023)

Comparison of the effects of probiotics, rifaximin, and lactulose in the treatment of minimal hepatic encephalopathy and gut microbiota
por: Wang, Ming-Wei, et al.
Publicado: (2023)

Protective efficacy of statins in patients with Klebsiella pneumoniae bloodstream infection
por: Xu, Qian, et al.
Publicado: (2023)

Convergent application of traditional Chinese medicine and gut microbiota in ameliorate of cirrhosis: a data mining and Mendelian randomization study
por: Zhou, Cheng, et al.
Publicado: (2023)

Rifaximin, Microbiota Biology, and Hepatic Encephalopathy
por: Peleman, Cedric, et al.
Publicado: (2016)

Efficacy and safety of novel carbapenem–β-lactamase inhibitor combinations: Results from phase II and III trials
por: Yu, Wei, et al.
Publicado: (2022)

Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective
por: Liu, Jiachen, et al.
Publicado: (2021)

Biofilm formation and antibiotic sensitivity in Elizabethkingia anophelis
por: Hu, Shaohua, et al.
Publicado: (2022)

Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy
por: Bajaj, Jasmohan S., et al.
Publicado: (2013)

Circadian Rhythms Coordinated With Gut Microbiota Partially Account for Individual Differences in Hepatitis B-Related Cirrhosis
por: Wang, Tongyao, et al.
Publicado: (2022)

Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome
por: Xiao, Lin, et al.
Publicado: (2021)

The gastrointestinal antibiotic resistome in pediatric leukemia and lymphoma patients
por: MacDonald, Tamara, et al.
Publicado: (2023)

In Vitro Activity Comparison of Ceftazidime–Avibactam and Aztreonam–Avibactam Against Bloodstream Infections With Carbapenem-Resistant Organisms in China
por: Yu, Wei, et al.
Publicado: (2021)

The neuromodulatory effects of flavonoids and gut Microbiota through the gut-brain axis
por: Wang, Haoran, et al.
Publicado: (2023)

Structure of gut microbiota and characteristics of fecal metabolites in patients with lung cancer
por: Lu, Xingbing, et al.
Publicado: (2023)

The Difference of Gut Microbiota and Their Correlations With Urinary Organic Acids Between Autistic Children With and Without Atopic Dermatitis
por: Hong, Ru-ping, et al.
Publicado: (2022)

Biomarkers of Gut Microbiota in Chronic Spontaneous Urticaria and Symptomatic Dermographism
por: Liu, Runqiu, et al.
Publicado: (2021)

Emergence of Neonatal Sepsis Caused by MCR-9- and NDM-1-Co-Producing Enterobacter hormaechei in China
por: Chen, Chunlei, et al.
Publicado: (2022)

Involvement of Abnormal Gut Microbiota Composition and Function in Doxorubicin-Induced Cardiotoxicity
por: Huang, Jie, et al.
Publicado: (2022)

The Role of Intestinal Bacteria and Gut–Brain Axis in Hepatic Encephalopathy
por: Chen, Zefeng, et al.
Publicado: (2021)

Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity
por: Kaji, Kosuke, et al.
Publicado: (2017)

Effects of Konjaku Flour on the Gut Microbiota of Obese Patients
por: Li, Yu, et al.
Publicado: (2022)

The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
por: Zhang, Yu-Lin, et al.
Publicado: (2022)

The Roles of the Gut Microbiota and Chronic Low-Grade Inflammation in Older Adults With Frailty
por: Xu, YuShuang, et al.
Publicado: (2021)

Characteristics of Gut Microbiota in Patients With Rheumatoid Arthritis in Shanghai, China
por: Sun, Yang, et al.
Publicado: (2019)

Alterations in Gut Microbiota of Gestational Diabetes Patients During the First Trimester of Pregnancy
por: Ma, Shujuan, et al.
Publicado: (2020)

Changes and significance of gut microbiota in children with focal epilepsy before and after treatment
por: Zhou, Changci, et al.
Publicado: (2022)

The Role of Gut Microbiota in Duodenal-Jejunal Bypass Surgery-Induced Improvement of Hepatic Steatosis in HFD-Fed Rats
por: Gao, Yi, et al.
Publicado: (2021)

The role of gut microbiota in gout: Is gut microbiota a potential target for gout treatment
por: Tong, Shuting, et al.
Publicado: (2022)

Comparative Studies of the Gut Microbiota in the Offspring of Mothers With and Without Gestational Diabetes
por: Crusell, Mie Korslund Wiinblad, et al.
Publicado: (2020)

Rifaximin in the treatment of hepatic encephalopathy
por: Iadevaia, Maddalena Diana, et al.
Publicado: (2011)

Impact of Gut Microbiota and Microbiota-Related Metabolites on Hyperlipidemia
por: Jia, Xiaokang, et al.
Publicado: (2021)

Gut microbiota and cardiac arrhythmia
por: Fan, Hongxuan, et al.
Publicado: (2023)

Probiotic Supplementation During Human Pregnancy Affects the Gut Microbiota and Immune Status
por: Chen, Yuyi, et al.
Publicado: (2019)

Gut Microbiota and Fecal Metabolites Associated With Neurocognitive Impairment in HIV-Infected Population
por: Dong, Ruihua, et al.
Publicado: (2021)

The Use of Rifaximin in Patients With Cirrhosis
por: Caraceni, Paolo, et al.
Publicado: (2021)

GW4064 Alters Gut Microbiota Composition and Counteracts Autism-Associated Behaviors in BTBR T+tf/J Mice
por: Liu, Jiayin, et al.
Publicado: (2022)

Variation of Serum Uric Acid Is Associated With Gut Microbiota in Patients With Diabetes Mellitus
por: Zhang, Weifeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f0iuqgfobr3abpn74pmd7hakd6